Apimeds Pharmaceuticals US, Inc. (APUS)
search
Earnings reactions
How APUS moved on each past earnings report.
Up
Down
Earnings Impact
Apimeds Pharmaceuticals US, Inc. (APUS) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Apimeds Pharmaceuticals US, Inc. (APUS) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 1 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
1
Funds holding
$10636
Total value held
Buying
1 added · 0 reduced
Ubs Group Ag
$10636
NEW BUY
SEC Filing Types
Recent SEC Filings
6 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260821 | open_in_new SEC.gov |
| 10-Q | 20260814 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 8-K | 20260713 | open_in_new SEC.gov |
| 10-Q | 20260526 | open_in_new SEC.gov |
| NT 10-Q | 20260515 | open_in_new SEC.gov |